30 Day Trial

Medicrea Posts 2015 Revenue

Share:

Medicrea posted 2015 revenue of €27.8MM (~US $30.2MM), +15% vs. 2014.

Company leadership called out late-2014 commercial investments that opened up new export markets during 2015, namely in South America and the eastern EU.

Further expansion in 2016 should gain support from distribution agreements inked in Asia and the Middle East, as well as creation of a German subsidiary and marketing entity in the U.K.

In France, the company's UNiD customized implant platform supported +23% growth for that region. Of total sales, the U.S. continues to account for 60%. 

Source: Medicrea